Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Epratuzumab[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
2Epratuzumab 100 MG[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
3Epratuzumab 1200 MG[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
4Epratuzumab 400 MG[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
5Epratuzumab 600 MG[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
6Epratuzumab IV[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
7Epratuzumab SC[1] Epratuzumab (Epratuzumab)[1] Epratuzumab (Epratuzumab) 💬 [1] CD22 💬 [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬